Experimental animal model for anthracycline-induced heart failure.

Suppr

超能文献

作者信息

Perik Patrick J, van den Berg Maarten P, de Vries Elisabeth G E, van Veldhuisen Dirk J

出版信息

Eur J Heart Fail. 2004 Jun;6(4):375-6. doi: 10.1016/j.ejheart.2003.12.017.

DOI:10.1016/j.ejheart.2003.12.017

PMID:15182760

Abstract

摘要

相似文献

Experimental animal model for anthracycline-induced heart failure.

Eur J Heart Fail. 2004 Jun;6(4):375-6. doi: 10.1016/j.ejheart.2003.12.017.

Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.

Eur J Heart Fail. 2004 Jun;6(4):377-87. doi: 10.1016/j.ejheart.2003.05.003.

Exposure to anthracyclines during childhood causes cardiac injury.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019.

[Dexrazoxane in anthracycline induced cardiotoxicity and extravasation].

Ned Tijdschr Geneeskd. 2010;154:A1155.

Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.

J Natl Cancer Inst. 2013 Jun 19;105(12):835-6. doi: 10.1093/jnci/djt161. Epub 2013 Jun 2.

Doxorubicin-induced cardiomyopathy.

N Engl J Med. 1999 Feb 25;340(8):654; author reply 655.

Anthracycline cardiotoxicity in children.

N Engl J Med. 2004 Jul 8;351(2):120-1. doi: 10.1056/NEJMp048113.

Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines.

Cancer Treat Rev. 2004 Nov;30(7):643-50. doi: 10.1016/j.ctrv.2004.06.002.

Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?

Circulation. 2006 Dec 5;114(23):2432-3. doi: 10.1161/CIRCULATIONAHA.106.666248.

Dexrazoxane in anthracycline extravasation.

J Clin Oncol. 2000 Aug;18(16):3064.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Experimental animal model for anthracycline-induced heart failure.

Eur J Heart Fail. 2004 Jun;6(4):375-6. doi: 10.1016/j.ejheart.2003.12.017.

Rabbit model for in vivo study of anthracycline-induced heart failure and for the evaluation of protective agents.

Eur J Heart Fail. 2004 Jun;6(4):377-87. doi: 10.1016/j.ejheart.2003.05.003.

Exposure to anthracyclines during childhood causes cardiac injury.

Semin Oncol. 2006 Jun;33(3 Suppl 8):S8-14. doi: 10.1053/j.seminoncol.2006.04.019.

[Dexrazoxane in anthracycline induced cardiotoxicity and extravasation].

Ned Tijdschr Geneeskd. 2010;154:A1155.

Cardiotoxicity debated for anthracyclines and trastuzumab in breast cancer.

J Natl Cancer Inst. 2013 Jun 19;105(12):835-6. doi: 10.1093/jnci/djt161. Epub 2013 Jun 2.

Doxorubicin-induced cardiomyopathy.

N Engl J Med. 1999 Feb 25;340(8):654; author reply 655.

Anthracycline cardiotoxicity in children.

N Engl J Med. 2004 Jul 8;351(2):120-1. doi: 10.1056/NEJMp048113.

Evaluating the role of dexrazoxane as a cardioprotectant in cancer patients receiving anthracyclines.

Cancer Treat Rev. 2004 Nov;30(7):643-50. doi: 10.1016/j.ctrv.2004.06.002.

Prediction and prevention of chemotherapy-induced cardiomyopathy: can it be done?

Circulation. 2006 Dec 5;114(23):2432-3. doi: 10.1161/CIRCULATIONAHA.106.666248.

Dexrazoxane in anthracycline extravasation.

J Clin Oncol. 2000 Aug;18(16):3064.